Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Commentary

Showing 1 - 10 of 201 Results.

Why Health Policy Problems Are Rarely Solved, Part II
John C. Goodman | Commentary | Aug. 26, 2024
The Whole US Should Follow Tennessee and Welcome Foreign Doctors
Abigail Devereaux | Commentary | Aug. 16, 2024
Why Health Policy Problems Rarely Get Solved
John C. Goodman | Commentary | Aug. 14, 2024
Newsom Continues Dreadful COVID-19 Crackdown
Reality dysphoria mounts across the Golden State.
K. Lloyd Billingsley | Commentary | July 19, 2024
Reason for Our Health Care Crisis: Government
John C. Goodman | Commentary | July 15, 2024
Thank Walmart, not Biden or Trump, for Lower Insulin Prices
Raymond J. March | Commentary | June 26, 2024
From Solzhenitsyn to US Governors: No Lessons Learned
The government’s pandemic regime reflected an authoritarian mindset more than good policy.
K. Lloyd Billingsley | Commentary | June 26, 2024
Common Sense as Health Policy
John C. Goodman | Commentary | June 14, 2024
Is There A Trump Health Care Plan?
John C. Goodman | Commentary | Apr. 8, 2024
Fauci and His Minions Are Still in Control
The time has come to hold Dr. Fauci and his cronies accountable for damages from the Covid pandemic.
K. Lloyd Billingsley | Commentary | Mar. 25, 2024






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL